NCT07675889

Brief Summary

The goal of this clinical trial is to learn whether intraoperative longitude-latitude-depth three-dimensional localization (LLD localization) is non-inferior to preoperative CT-guided percutaneous lung puncture localization for identifying 0.8-2 cm peripheral pulmonary nodules in adults undergoing video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection. It will also evaluate the safety and perioperative effectiveness of the two localization methods. The main questions it aims to answer are:

  1. 1.Is the localization accuracy rate of LLD localization non-inferior to that of CT-guided percutaneous lung puncture localization?
  2. 2.Does LLD localization improve perioperative outcomes, including localization time, postoperative recovery, pain, quality of life, and perioperative complication rates?
  3. 3.Be randomly assigned in a 1:1 ratio to either the LLD localization group or the CT-guided percutaneous lung puncture localization group.
  4. 4.Undergo pulmonary nodule localization using the assigned localization method.
  5. 5.Receive VATS-assisted sublobar resection following localization.
  6. 6.Be assessed for localization accuracy, perioperative complications, localization time, postoperative chest drainage tube removal time, oxygenation index, postoperative hospital stay, pain scores, and quality-of-life outcomes.
  7. 7.Complete follow-up assessments at 1, 3, and 6 months after surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P75+ for not_applicable

Timeline
23mo left

Started Jul 2026

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Jul 2026Jul 2028

First Submitted

Initial submission to the registry

June 23, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

June 23, 2026

Last Update Submit

June 23, 2026

Conditions

Keywords

Peripheral Pulmonary NodulePulmonary Nodule LocalizationLongitude-Latitude-Depth LocalizationCT-Guided Percutaneous LocalizationVideo-Assisted Thoracoscopic SurgerySublobar ResectionRandomized Controlled TrialNon-Inferiority Trial

Outcome Measures

Primary Outcomes (1)

  • Localization Accuracy Rate

    Localization accuracy rate is defined as the percentage of participants with successful localization, calculated as (number of successfully localized participants / total number of participants) Ă— 100%. Localization is deemed successful if the actual distance between the localization point and the true nodule center, or its surface projection, is 1 cm or less. A distance exceeding 1 cm is classified as localization failure. After removal of the pulmonary nodule, measure the distance from the nodule center to the marked localization point with a ruler and record the value.

    Intraoperatively on day 0.

Secondary Outcomes (7)

  • Perioperative Complication Rate

    From the initiation of the localization procedure through hospital discharge, up to 14 days post-surgery.

  • Localization Time

    During the localization procedure on day 0 (from the start of localization to its confirmed completion, approximately 5-20 minutes).

  • Postoperative Chest Drainage Tube Removal Time

    From the completion of surgery to chest drainage tube removal, assessed up to 14 days post-surgery.

  • Oxygenation Index

    Postoperative day 1 and day 2.

  • Postoperative Length of Hospital Stay

    From the completion of surgery to hospital discharge, assessed up to 30 days.

  • +2 more secondary outcomes

Study Arms (2)

Longitude-Latitude-Depth Localization Group

EXPERIMENTAL

Participants assigned to this arm will undergo intraoperative longitude-latitude-depth (LLD) localization of peripheral pulmonary nodules. The localization method uses anatomical reference lines and preoperative imaging measurements to determine the three-dimensional position of the target nodule during surgery. Following localization, participants will undergo video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection according to standard surgical practice.

Procedure: Longitude-Latitude-Depth Localization

CT-Guided Percutaneous Lung Puncture Localization Group

ACTIVE COMPARATOR

Participants assigned to this arm will undergo preoperative CT-guided percutaneous pulmonary nodule localization according to institutional standard practice. Following localization, participants will undergo video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection according to standard surgical practice.

Procedure: CT-Guided Percutaneous Lung Puncture Localization

Interventions

The longitude-latitude-depth (LLD) localization method is a novel intraoperative three-dimensional pulmonary nodule localization technique developed for peripheral pulmonary nodules. Based on preoperative computed tomography (CT) imaging, the target lesion is characterized according to its longitudinal position, transverse position, and depth relative to the visceral pleural surface. During surgery, corresponding anatomical landmarks on the collapsed lung are identified, and the projected surface location and lesion depth are used to estimate the three-dimensional position of the target nodule. Localization is performed intraoperatively without preoperative transcutaneous puncture or placement of localization materials. The identified localization point is subsequently used to guide video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection of the target lesion.

Longitude-Latitude-Depth Localization Group

CT-guided percutaneous lung puncture localization is a preoperative localization procedure performed under computed tomography guidance. A localization device is inserted through the chest wall into the lung parenchyma to mark the location of the target pulmonary nodule before surgery. Following localization, the position of the marker relative to the nodule is confirmed by CT imaging. The localization result is subsequently used to guide video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection.

CT-Guided Percutaneous Lung Puncture Localization Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically diagnosed pulmonary nodule by non-contrast chest CT.
  • Age 18 to 80 years.
  • Expected survival time of at least 12 months.
  • Single peripheral pulmonary nodule with a diameter between 0.8 cm and 2 cm.
  • Chest CT characteristics meeting both of the following criteria:
  • Solid component proportion ≤50%.
  • Located subpleurally or in the outer one-third of the lung parenchyma.
  • Willing to undergo VATS-assisted sublobar resection.
  • No contraindications to pulmonary localization procedures or surgery.
  • Able to understand the study and willing to sign written informed consent.

You may not qualify if:

  • Use of other localization methods or other surgical procedures.
  • Concurrent participation in another clinical study.
  • Pregnancy.
  • Unwillingness or inability to cooperate with participation in this study for any reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Xingyi People's Hospital

Xingyi, Guizhou, 562400, China

Location

Ningxia Hui Autonomous Region People's Hospital

Yinchuan, Ningxia, 750021, China

Location

Qilu Hospital of Shandong University

Jinan, Shandong, 250012, China

Location

Linqing People's Hospital

Linqing, Shandong, 252600, China

Location

Related Publications (7)

  • Zhao Y, Qiu J, Bright A, Zhao R, Li R, Tang Z, Yue W, Tian H, Sun Z. Intraoperative longitude-latitude-depth three-dimensional localization of pulmonary nodules. Transl Lung Cancer Res. 2025 Jan 24;14(1):260-271. doi: 10.21037/tlcr-2024-1170. Epub 2025 Jan 22.

    PMID: 39958213BACKGROUND
  • Suzuki K, Nagai K, Yoshida J, Ohmatsu H, Takahashi K, Nishimura M, Nishiwaki Y. Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking. Chest. 1999 Feb;115(2):563-8. doi: 10.1378/chest.115.2.563.

    PMID: 10027460BACKGROUND
  • Zhang B, Zhang Y, Le H, Li W, Chen C, Fang R, Pan X. Intraoperative localization in minimally invasive surgery for small pulmonary nodules: a retrospective study. Transl Cancer Res. 2021 Jul;10(7):3470-3478. doi: 10.21037/tcr-21-1059.

    PMID: 35116651BACKGROUND
  • Zhou C, Li X, Li W, Qian J. Clock dial integrated positioning combined with single utility port video-assisted thoracoscopic surgery: a new localization method for lung tumors. J Thorac Dis. 2021 Feb;13(2):1143-1150. doi: 10.21037/jtd-20-3312.

    PMID: 33717587BACKGROUND
  • Qiu B, Ji Y, He H, Zhao J, Xue Q, Gao S. Three-dimensional reconstruction/personalized three-dimensional printed model for thoracoscopic anatomical partial-lobectomy in stage I lung cancer: a retrospective study. Transl Lung Cancer Res. 2020 Aug;9(4):1235-1246. doi: 10.21037/tlcr-20-571.

    PMID: 32953501BACKGROUND
  • Park CH, Han K, Hur J, Lee SM, Lee JW, Hwang SH, Seo JS, Lee KH, Kwon W, Kim TH, Choi BW. Comparative Effectiveness and Safety of Preoperative Lung Localization for Pulmonary Nodules: A Systematic Review and Meta-analysis. Chest. 2017 Feb;151(2):316-328. doi: 10.1016/j.chest.2016.09.017. Epub 2016 Oct 4.

    PMID: 27717643BACKGROUND
  • Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, Enyioha C, Malo TL, Brenner AT, Armstrong C, Coker-Schwimmer M, Middleton JC, Voisin C, Harris RP. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021 Mar 9;325(10):971-987. doi: 10.1001/jama.2021.0377.

    PMID: 33687468BACKGROUND

MeSH Terms

Conditions

Solitary Pulmonary NoduleMultiple Pulmonary Nodules

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasms

Central Study Contacts

Zhenguo Sun, Doctor of Medicine (MD)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to either the intraoperative longitude-latitude-depth (LLD) localization group or the preoperative CT-guided percutaneous localization group. This is a multicenter, open-label, parallel-group, non-inferiority trial designed to evaluate whether LLD localization provides non-inferior localization accuracy compared with conventional CT-guided localization for peripheral pulmonary nodules.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 23, 2026

First Posted

June 30, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

To protect participant privacy and maintain clinical data confidentiality, individual participant data will not be made publicly available.

Locations